A Phase 3b Open-label Study of S-888711 in Thrombocytopenic Patients with Chronic Liver Disease

Trial Profile

A Phase 3b Open-label Study of S-888711 in Thrombocytopenic Patients with Chronic Liver Disease

Completed
Phase of Trial: Phase III

Latest Information Update: 22 Nov 2017

At a glance

  • Drugs Lusutrombopag (Primary)
  • Indications Thrombocytopenia
  • Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
  • Sponsors Shionogi
  • Most Recent Events

    • 14 Nov 2017 Status changed from active, no longer recruiting to completed.
    • 11 Oct 2016 Status changed from recruiting to active, no longer recruiting.
    • 15 Jun 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top